Measurement and clinic applications of homocysteine and methylated arginines

Doctoral thesis English OPEN
Weaving, Gary Ronald (2010)
  • Subject: QD | QH301 | QM

Homocysteine is an amino acid formed by the metabolism of methionine. Increased plasma homocysteine concentrations are associated with cardiovascular disease, and it has been suggested that homocysteine lowering therapy may reduce cardiovascular risk. Plasma homocysteine measurements are frequently requested by clinicians investigating patients with vascular disease. A mechanism for homocysteine causing vascular disease has not yet been proven, but one possibility is that an elevated plasma homocysteine concentration may lead to the accumulation of asymmetric dimethylarginine (ADMA), a naturally occurring amino acid that inhibits nitric oxide synthase, resulting in impaired nitric oxide production, and therefore vascular dysfuntion. The aim of this project was to develop analytical methods suitable for the measurement of homocysteine and related metabolites in a routine clinical laboratory, and two methods have been established; i) for homocysteine, cysteine and methionine and ii) for asymmetric dimethylarginine, symmetric dimethylarginine (SDMA, a sterioisomer of ADMA), monomethylarginine (MMA) and arginine. A novel feature of the method for ADMA is that the use of unique daughter ions allows the determination of both ADMA and SDMA without the need to separate the isomers chromatographically. In addition, the synthesis and application of isotopically labelled SDMA, for use as an internal standard, is described for the first time. When the methods were applied to the analysis of routine clinical samples no association was detected between plasma total homocysteine and plasma ADMA concentrations. Measurements were also performed on samples from patients enrolled in a clinical trial investigating the progression of vascular dysfuntion, as measured by carotid-femoral pulse wave velocity (CF-PWV), in chronic kidney disease. Again no association could be found between plasma total homocysteine and plasma ADMA concentrations. In addition plasma total homocysteine was not a determinant of CF-PWV. These findings do not support the hypothesis that hyperhomocysteinaemia causes vascular disease by increasing ADMA concentrations.
  • References (22)
    22 references, page 1 of 3

    www.heartstats.org accessed 3/04/2010.

    Ross R. (1999) Atherosclerosis - an inflammatory disease. New Engl J Med 340, 115-126.

    Wang TJ, (2008) New cardiovascular risk factors exist, but are they clinically useful? Eur Heart J 29, 441-444.

    Shishehbor MH, Oliveira LPJ, Lauer MS, Sprecher DL, Wolski K, Cho L, Hoogwerf BJ, Hazen, SL. (2008) Emerging cardiovascular risk factors that account for a significant portion of attributable mortality risk in chronic kidney disease. Am J Cardiol 101, 1741-1746.

    Yap S, Boers GHJ, Wilcken B, Wilcken DEL, Brenton DP, Lee PJ, Walter JH, Howard PM, Naughten ER. (2001) Vascular outcome in patients with 13 14 15 16 17 18 19 20 21 Ogino S, Wilson RB. (2003) Genotype and haplotype distributions of MTHFR 677C>T and 1298A>C single nucleotide polymorphisms: a meta-analysis. J Hum Genetics 48, 1-7.

    24 Wald DS, Law M, Morris JK. (2002) Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325, 1202-1208.

    Bønaa KH, Njølstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K. (2006) Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354, 1578- 1588.

    Signorello MG, Segantin A, Passalacqua M, Leoncini G. Homocysteine decreases platelet NO level via protein kinase C activation. Nitic Oxide 20, 104-113.

    Carlucci F, Tabucchi A. (2009) Capillary electrophoresis in the evaluation of aminothiols in body fluids. J Chrom B 877, 3347-3357.

    Pfeiffer CM, Huff DL, Gunter EW. (1999) Rapid and accurate HPLC assay for plasma total homocysteine and cysteine in a clinical laboratory setting. Clin Chem 45, 290-292.

  • Metrics
    No metrics available
Share - Bookmark